Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ferrocene Phosphinimine Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel imidazolium-functionalized ferrocene ligands enable high-yield asymmetric allylic substitution with recyclable catalyst properties for pharmaceutical intermediates.
Patent CN101486737A discloses a novel quaternary ammonium ferrocene ligand enabling high-yield asymmetric allylic substitution with simplified catalyst recovery for cost-effective manufacturing.